Icade (ICAD) Q4 2024 earnings summary

Executive summary

• 2024 Group net current cash flow (NCCF) reached €3.98 per share, exceeding guidance, driven by resilient Property Investment and early steps in the ReShape strategic plan, including diversification into student residences and data centers.

• Dividend for 2024 proposed at €4.31 per share, including €2.54 from the Healthcare business sale.

• Group carbon emissions reduced by 44% since 2019, with strong ESG ratings and enhanced sustainability incentives.

• Property development performance was mixed, with a challenging first half and improved individual orders in the second half.

• The balance sheet remains solid with high liquidity and reasonable LTV.

Financial highlights

• Group NCCF totaled €301.8 million (€3.98/share), down 13.9% year-over-year due to Healthcare deconsolidation; strategic activities contributed €223 million.

• EPRA NTA per share declined by ~11% to €60.1; net profit at -€317.2 million, reflecting property portfolio devaluation.

• Gross rental income from property investment rose 2.5% like-for-like to €369.2 million; property development revenues stable at €1.2 billion.

• LTV increased to 36.5% from 33.5%; net debt to EBITDA at 10x, impacted by impairments.

• EBITDA dropped 14.8% to €239 million, impacted by €85 million property development depreciation.

Outlook and guidance

• 2025 NCCF guidance set at €3.40–€3.60 per share, reflecting lower non-strategic operations contribution and no expected dividends from IHE or Præmia Healthcare.

• Property revenues expected to decline in 2025 due to lower indexation impact and full-year effect of 2024 tenant departures.

• Property development expected to return to breakeven in 2025, but recovery pace remains uncertain.

• Dividend policy remains conservative, prioritizing cash retention for redeployment and growth until repositioning is finalized.

• Cautious outlook due to persistent macroeconomic and political uncertainties, especially in France.